Peer-influenced content. Sources you trust. No registration required. This is HCN.
Renal & Urology News
New research reveals significant differences in overall survival rates based on the site of visceral metastases in metastatic prostate cancer. Discover how these insights could shape your approach to patient care.
Oncology, Radiation September 5th 2023
Clinical Advances in Hematology & Oncology
The ASCO 2023 meeting has unveiled key studies in prostate cancer, including insights into PSA levels post-radiation therapy, the role of BRCA mutations, and promising combination therapies.
Oncology, Medical August 21st 2023
Oncology Learning Network
The FDA’s approval of the olaparib, abiraterone, and prednisone regimen for BRCA-mutated mCRPC, based on the PROpel trial, could significantly alter the treatment landscape. Learn more about this promising development in prostate cancer therapy.
Oncology, Medical August 7th 2023
Cancer Therapy Advisor
Second-generation androgen receptor pathway inhibitors (ARPIs) have proven to be essential in managing nonmetastatic castration-resistant prostate cancer (nmCRPC). These treatments provide hope in delaying metastasis and improving overall survival, significantly altering the disease’s prognosis.
Oncology, Medical July 18th 2023
SingleCare
Explore how the age-old remedy of apple cider vinegar might offer modern benefits for men’s health, including weight management, blood sugar control, and cholesterol reduction.
All Specialties June 21st 2023
ScientiaCME
Addressing the Underrecognized Issue of Male Osteoporosis: Evidence-based Strategies for Improved Detection and Management As the elderly population increases, osteoporosis in men, a condition often underdiagnosed and overlooked, is gaining significant prominence in public health. This self-learning activity enables healthcare professionals to gain critical insight into this issue and empower them with the latest evidence-based preventive and therapeutic strategies.
Clinical Pharmacology June 7th 2023